Vanda Pharmaceuticals Expanded Access Policy

Vanda Pharmaceuticals Expanded Access Policy

Vanda is committed to making investigational products available to patients with high unmet medical needs who have exhausted other treatment options. This policy describes the request procedures for expanded access to Vanda investigational products to patients outside of a clinical study.

Expanded Access Requests.

A treating physician or patient may submit questions or requests regarding expanded access to expandedaccess@vandapharma.com or call us at 202-734-3400. We review all expanded access requests as quickly as possible, and evaluate each request on a case-by-case basis. Typically, we will acknowledge the receipt of requests or questions within one business day of receipt.

Current Expanded Access Programs.

This page will be updated with a hyperlink to the expanded access record on clinicaltrials.gov for current expanded access programs.

HETLIOZ®

Non-24-House Sleep-Wake Disorder

HETLIOZAccess™ For Patients outside of the U.S.